SpyGlass Pharma, Inc

Graybug Vision

The company develops sustained-release injectable medicines for patients with retinal diseases and glaucoma to reduce the frequency of ocular treatments.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

VisusNano

This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.

Perfuse Therapeutics

The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.

Rheon Medical SA

This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

Envisia

This clinical-stage biotechnology company develops extended-release ocular therapies for patients with glaucoma and other eye disorders.

Aquesys

This company develops and manufactures ocular implants for glaucoma patients to reduce intraocular pressure through minimally invasive surgical procedures.